"We're poised to treat our first patient, which is really exciting." Prof Chris Shaw, Group Leader at UK DRI at King's, shares how early support from the Institute helped transform his gene therapy research for MND/ALS & FTD into international clinical trials 👇 youtu.be/9eG6M5UPWz4?...